Literature DB >> 9039291

Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.

K Rossen1, T Haerslev, K Hou-Jensen, G K Jacobsen.   

Abstract

Basaloid proliferations overlying dermatofibromas which morphologically resemble superficial basal cell carcinomas have been interpreted as both reactive/regressive and frankly malignant. Metallothioneins (MTs) are low-molecular-weight proteins with a selective binding affinity for heavy metal ions. MTs has been proposed to represent a biological marker of carcinogenesis and, in a variety of human tumours, a correlation between immunohistochemically overexpression of MT and aggressive clinical behaviour has been shown. In order to clarify the nature of basaloid proliferations overlying dermatofibromas, we examined, immunohistochemically, 10 dermatofibromas with overlying simple hyperplasia, 16 dermatofibromas with overlying basaloid proliferation, and 35 basal cell carcinomas, for expression of MT. In normal epidermis, the basal keratinocytes showed cytoplasmatic MT immunoreactivity. The staining intensity was stronger in the basal cells of the rete ridges, an observation which is in accordance with the high proportion of S-phase cells in this area. Simple hyperplasia showed the same MT expression pattern as normal epidermis. Basaloid proliferations stained like superficial and nodular basal cell carcinomas. Of nodular basal cell carcinomas, 92% (12 of 13) showed decreased/absent MT immunoreactivity, while 86% (six of seven) of infiltrating/morphoea-like basal cell carcinomas showed overexpression of MT (P = 0.001, Fisher's exact test). The results demonstrate that MT overexpression in basal cell carcinomas is correlated with infiltrative growth pattern. The similar expression of MT in basaloid proliferations and 'non-infiltrating' basal cell carcinomas suggests that these lesions share a common change in metabolism and/or differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039291

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit.

Authors:  K O Alsaad; N A Obaidat; D Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

2.  Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene.

Authors:  Yong-Ping Cui; Jian-Bo Wang; Xin-Yu Zhang; Mei-Xia Bi; Li-Ping Guo; Shih-Hsin Lu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

4.  Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.

Authors:  Aleksandra Zamirska; Łukasz Matusiak; Piotr Dziegiel; Grażyna Szybejko-Machaj; Jacek C Szepietowski
Journal:  Pathol Oncol Res       Date:  2012-03-10       Impact factor: 3.201

5.  Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.

Authors:  G Weinlich; K Eisendle; E Hassler; M Baltaci; P O Fritsch; B Zelger
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

Review 6.  Metallothionein Lower Under-Expression in Benign Tumors than That in Malignant Tumors: Systematic Review Article and Meta-Analysis.

Authors:  Jie Zhang; Ruijie Sun; Yue Liu; Guinian Wang; Qinglu Wang
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

Review 7.  The roles of metallothioneins in carcinogenesis.

Authors:  Manfei Si; Jinghe Lang
Journal:  J Hematol Oncol       Date:  2018-08-23       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.